Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antibiotic Prophylaxis in Pediatric Open Fractures
NCT06055712Phase 4Enrolling by invitation
- Sponsor
- Saint Louis University
- Start
- Sep 2023
- Primary completion
- Sep 2033
- Modality
- Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of cefazolin and cefalexin in bacterial infection (3 arms), sponsored by Saint Louis University. Primary endpoint: Number of participants with an infection at the fracture site at 3 months. Started Sep 2023; status: enrolling by invitation.
02
Drugs
cefazolincefalexin
03
Conditions
bacterial infection
Beyond the preview
Go deeper on NCT06055712.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06055712.